JAMA Network Open is a premier open-access journal published by the American Medical Association, dedicated to advancing the field of medicine through the dissemination of high-quality research. With an ISSN of 2574-3805, this journal has emerged as a vital platform since its launch in 2018, granting unrestricted access to groundbreaking studies and innovative findings in various areas of medicine. Currently boasting an impressive impact factor and ranking in the top 4% (Q1) of General Medicine, JAMA Network Open holds the 23rd position among 636 journals in the medicine category on Scopus, solidifying its status as an influential contributor to the medical community. Aiming to foster collaborative learning and evidence-based practice, the journal attracts submissions from researchers, healthcare professionals, and students alike. By providing a robust forum for research dissemination and engagement, JAMA Network Open plays a crucial role in shaping contemporary medical discourse and enhancing patient care globally.

The American Journal of Translational Research is a pivotal publication in the fields of Biochemistry, Genetics, and Molecular Biology, dedicated to advancing the understanding of translational science and its applications in clinical settings. Published by E-CENTURY PUBLISHING CORP, this journal, under ISSN 1943-8141, fosters scholarly exchange by publishing original research articles, reviews, and clinical studies that bridge the gap between laboratory discoveries and actual medical practice. Although its coverage in Scopus has been discontinued, the journal has previously held respectable rankings, including a 64th percentile in Clinical Biochemistry and 52nd in both Molecular Medicine and Cancer Research, indicating its influence and relevance in the scientific community. With its formal objective of disseminating significant findings that inform clinical practices, the journal remains a valuable resource for researchers, healthcare professionals, and students eager to stay at the forefront of translational research advancements.

Journal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.

LIFE SCIENCES, published by PERGAMON-ELSEVIER SCIENCE LTD, is an esteemed international journal that has been advancing the field since its inception in 1962. With an ISSN of 0024-3205 and an E-ISSN of 1879-0631, it serves as a critical forum for researchers, professionals, and students within the realms of biochemistry, genetics, molecular biology, medicine, and pharmacology. Currently ranked in the Q1 category across multiple disciplines, including a remarkable 2nd rank in General Pharmacology, Toxicology, and Pharmaceutics, the journal maintains a prestigious position in academic circles, evidenced by its high impact factor and significant percentile ranks. While LIFE SCIENCES is not an open-access journal, it remains dedicated to publishing high-quality, peer-reviewed research that pushes the boundaries of knowledge and fosters innovation. With converged research interests leading into 2024, LIFE SCIENCES continues to be a pivotal resource for the dissemination of influential findings, making it an indispensable tool for those engaged in the life sciences.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

The Annual Review of Medicine is a prestigious academic journal published by Annual Reviews that serves as a key resource for researchers, healthcare professionals, and students engaged in the fields of medicine and biochemistry. With its ISSN 0066-4219 and E-ISSN 1545-326X, this journal has been providing comprehensive reviews that cover major developments and trends in medical research since its inception in 1950. Impactful in its category, the Annual Review of Medicine ranks in the Q1 quartile for both Medicine (miscellaneous) and Biochemistry, Genetics and Molecular Biology (miscellaneous), establishing itself within the top percentiles of academic rigor and relevance, exemplified by its impressive Scopus rankings: Rank #12/636 and Rank #6/221 respectively. Although the journal is not open access, it remains an essential resource for contributing valuable insights into evolving medical disciplines, driving evidence-based practice, and fostering innovation among healthcare researchers. The Annual Review of Medicine is instrumental in shaping the future of medicine by synthesizing the most critical findings and fostering an informed understanding of diverse medical challenges.

INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, published by the NATL INST SCIENCE COMMUNICATION-NISCAIR, stands as a significant platform for the dissemination of original research in the fields of biochemistry, genetics, and molecular biology, particularly within the context of Indian scientific advancements. With its ISSN 0019-5189 and E-ISSN 0975-1009, the journal has been an essential resource since its inception in 1965, although coverage in prominent databases like Scopus was discontinued in 2018. The journal ranks in the 57th percentile for Biotechnology, as well as in the 27th and 25th percentiles for Molecular Biology and Cell Biology respectively, underscoring its impact and relevance. While currently not an Open Access journal, it continues to provide valuable insights and contributions from researchers and professionals in the growing field of experimental biology. The esteemed contributions published in this journal enhance our understanding of biological processes and foster the development of innovative solutions to contemporary challenges in health and environmental science.

Biomolecules and Biomedicine is a pioneering open-access journal dedicated to advancing the fields of molecular biology and biomedical sciences, published by the Association of Basic Medical Science Federation Bosnia & Herzegovina in Sarajevo. With the ISSN 2831-0896 and the E-ISSN 2831-090X, this journal aims to facilitate the dissemination of high-quality research from 2023 onwards, inviting submissions that provide innovative insights and findings across various facets of medicine and biological sciences. Positioned within the General Medicine and Biochemistry, Genetics and Molecular Biology categories, it currently holds rankings of 332 out of 636 and 173 out of 221 respectively, highlighting its emerging influence in these fields. As an open-access journal, it ensures that all published research is freely accessible to a global audience, fostering collaboration and knowledge exchange among researchers, professionals, and students alike. With a commitment to enhancing scientific discourse and promoting cutting-edge research, Biomolecules and Biomedicine is poised to become a vital resource for those dedicated to unraveling the complexities of biomolecules and their roles in health and disease.

BioMedicine-Taiwan, published by DIGITAL COMMONS BEPRESS, stands as a prominent open-access journal that has been disseminating vital research since 2014. With an ISSN of 2211-8020 and E-ISSN 2211-8039, this journal covers a wide array of disciplines within the biomedical field, reaching researchers and professionals keen on exploring cutting-edge advancements and innovative approaches in biochemistry, genetics, and general medicine. Notably categorized as Q2 in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine for 2023, BioMedicine-Taiwan ranks well in its respective fields, reflecting its commitment to enhancing scholarly communication and knowledge dissemination. Situated in Taiwan, its impact is further highlighted by its Scopus rankings—placing it in the 70th percentile for general medicine and 47th percentile for general biochemistry and molecular biology, showcasing its significance in ongoing biomedical discourse. Researchers, students, and professionals are invited to engage with this invaluable resource to explore the latest findings and developments that shape the future of healthcare and biological sciences.